Actuate Therapeutics holds 2026 Annual Meeting; elects Fletcher and Keyes as directors, ratifies Crowe LLP as auditor

ACTUATE THERAPEUTICS, INC.

Elected Aaron G.L. Fletcher, Ph.D. and Jason Keyes as Class II directors for three-year terms through 2029.
Fletcher received 14,877,247 for, 1,883,025 withheld; Keyes received 16,727,875 for, 32,397 withheld.
Ratified Crowe LLP as independent auditor for FY 2026 with 18,571,817 for, 50,023 against, 9,741 abstain.
Broker non-votes: 1,871,309 on director elections; none on auditor ratification.

item 5.07

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001683168-26-004268
form_type: 8-K
ticker: ACTU
cik: 0001652935
company_name: ACTUATE THERAPEUTICS, INC.
filed_at: 2026-05-22T20:43:53+00:00
discovered_at: 2026-05-22T20:45:01.391830+00:00
generated_at: 2026-05-22T20:51:58.251881+00:00
sec_items: ["5.07"]
event_type: other
sentiment: neutral
materiality_score: 0.1
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001683168-26-004268
json_url: https://secwatch.observer/filing/0001683168-26-004268.json
markdown_url: https://secwatch.observer/filing/0001683168-26-004268.md
text_url: https://secwatch.observer/filing/0001683168-26-004268.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/1652935/000168316826004268/0001683168-26-004268-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/1652935/000168316826004268/actuate_8k.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Source: SEC EDGAR

accession 0001683168-26-004268

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.